The mRNA vaccine, a swift warhead against a moving infectious disease target
Introduction The rapid development of mRNA vaccines against SARS-CoV-2 has revolutionized vaccinology, offering hope for swift responses to emerging infectious diseases. Initially met with skepticism, mRNA vaccines have proven effective and safe, reducing vaccine hesitancy amid the evolving COVID-19...
Saved in:
Main Authors: | Sheema Mir, Mohammad Mir |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Expert Review of Vaccines |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/14760584.2024.2320327 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity of DNA, mRNA and Subunit Vaccines Against Beak and Feather Disease Virus
by: Buyani Ndlovu, et al.
Published: (2025-07-01) -
Nanoparticle-Based mRNA Vaccine Induces Protective Neutralizing Antibodies Against Infectious Bronchitis Virus in In-Vivo Infection
by: Aseno Sakhrie, et al.
Published: (2025-05-01) -
Research progress on the quality control of mRNA vaccines
by: Chaoying Hu, et al.
Published: (2024-12-01) -
Novel Bivalent mRNA‐LNP Vaccine for Highly Effective Protection against Pneumonic Plague
by: Uri Elia, et al.
Published: (2025-07-01) -
A Systematic Review of Clinical Trials Using mRNA Vaccines for Infectious Diseases other than COVID-19
by: Athina Sofroniou, et al.
Published: (2025-07-01)